Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 6086 results found. Search for [ candidates ]

Results 1 to 21 of 6086
BusinessToday.In
New Delhi, December 3, 2020
India, which has its own promising vaccine candidates, is yet to strike a deal with Pfizer. Experts believe that the need for ultra-low storage temperature (-70 degree celsius) and high cost of pfizer makes the vaccine unviable for India. Watch the video for more.


Manoj Sharma
December 2, 2020
Pfizer and BioNTech vaccine: The UK has already ordered 40 million doses of the Pfizer vaccine to vaccinate its 20 million population, of which around 10 million doses will be available soon


Joe C Mathew
December 2, 2020
Of the 8,936 respondents, 59 percent say they will not rush to vaccinate themselves against the pandemic even if it is made available by February 2021


PB Jayakumar
December 1, 2020
Ministry of Health and Family Welfare is in discussion with three suppliers to place orders for syringes or is seeking to prepone deliveries of already placed orders with them


BusinessToday.In
November 30, 2020
As number of patients has doubled from 95 to 196, Moderna has reported a drop in efficacy for its COVID-19 vaccine from 94.5 per cent to 94.1 per cent


PTI
November 30, 2020
Citing data from across states, India Ratings and Research said state governments need to galvanise the local bureaucracy and leverage both the soft and hard infrastructure, along with the healthcare spends, for favourable outcomes on this front


Reuters
November 30, 2020
The U.K. left the EU on Jan. 31, but remained part of the 27-nation bloc's economic embrace during an 11-month transition as the two sides tried to negotiate a new free-trade deal to take effect Jan. 1


Mohammad Haaris Beg
November 30, 2020
The coronavirus is known to cause respiratory infection in patients who are affected by it. Air Hunger is a symptom of the damage done to the lungs by the infection brought on by COVID-19


Associated Press
November 30, 2020
Multiple vaccine candidates must succeed for the world to stamp out the pandemic, which has been on the upswing in the US and Europe. US hospitals have been stretched to the limit as the nation has seen more than 160,000 new cases per day


Chitranjan Kumar
November 30, 2020
Primary efficacy analysis of the Phase 3 COVE study of Moderna' COVID-19 vaccine involved 30,000 participants included 196 cases of COVID-19, of which 30 cases were severe


BusinessToday.In
November 30, 2020
There are only five companies that have given preliminary data about how effective their vaccines could be to fight against coronavirus. These five companies include Pfizer-BioTech, Moderna Inc, Oxford University-AstraZeneca Plc, and Gamaleya Institute


BusinessToday.In
November 29, 2020
India to develop vaccines for 60 percent of developing nations; 24 manufacturing units among 19 firms to develop vaccine in India: Bhargava


BusinessToday.In
November 29, 2020
As coronavirus cases continue to rise, the UK plans to move fast in the approval process and clearance to Pfizer and BioNTech SE could come by next week


Reuters
November 28, 2020
Poonawalla said in the next few weeks SII plans to apply for emergency use authorization for AstraZeneca's COVID-19 vaccine candidate that he described as a 'very good' option


BusinessToday.In
November 28, 2020
Delhi Health Minister Satyendra Jain also said that the vaccination will be administered to all people residing in the National Capital with the help of health facilities such as polyclinics


BusinessToday.In
November 27, 2020
After the publication of early data from phase-3 clinical trials, drugmakers Pfizer and BioNTech have sought regulatory approval to deploy their inoculation under emergency-use rules. American biotech company Moderna is also likely to do the same soon


BusinessToday.In
November 27, 2020
Serum Institute of India is expected to produce 100 crore doses of the Oxford-AstraZeneca vaccine candidate. These doses will be given to middle and low-income countries, including India. SII has now agreed to provide 3 crore doses to Bangladesh


PTI
November 27, 2020
The mission envisages Covid-19 vaccine development with end-to-end focus from preclinical through clinical development and manufacturing and regulatory facilitation, the DBT said


BusinessToday.In
November 27, 2020
The company could be looking at manufacturing 100 million doses to begin with, as per Chairman Pankaj Patel.


PTI
November 27, 2020
India assured the people of Nepal that once it rolls out a vaccine against COVID-19, meeting their requirement will be a priority for New Delhi, amid a spike of the deadly disease in the Himalayan nation


PAGES 1 OF 305  12345